Brakewood Harold Eugene bought IMRX
February 3, 2026 · Form 4 insider transaction
Brakewood Harold Eugene bought 140,000 shares of Immuneering Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
140,000
Price
$0.00
Total value
N/A
InsiderBrakewood Harold Eugene
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2026
Filing dateFebruary 5, 2026
Shares owned after140,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030.